Cover Image
市場調查報告書

急性缺血性腦中風的診斷及治療的全球市場預測:2014∼2020年 (各診斷:CT、核磁共振攝影、超音波、腦血管造影術、核子醫學攝影、各手術:頸動脈內薄膜剝離術、血管新生、血管內機械性血栓消除術)

Acute Ischemic Stroke Diagnosis and Treatment Market (By Diagnostics Type - CT, MRI, Ultrasound, Cerebral Angiography, Nuclear Imaging, By Surgery Type) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

出版商 Transparency Market Research 商品編碼 332545
出版日期 內容資訊 英文 88 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
急性缺血性腦中風的診斷及治療的全球市場預測:2014∼2020年 (各診斷:CT、核磁共振攝影、超音波、腦血管造影術、核子醫學攝影、各手術:頸動脈內薄膜剝離術、血管新生、血管內機械性血栓消除術) Acute Ischemic Stroke Diagnosis and Treatment Market (By Diagnostics Type - CT, MRI, Ultrasound, Cerebral Angiography, Nuclear Imaging, By Surgery Type) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
出版日期: 2014年08月07日 內容資訊: 英文 88 Pages
簡介

急性缺血性腦中風,由於動脈內的動脈粥狀硬化造成的斑塊和血栓使血管破損,阻礙腦的血流。可能因此而引起大腦動脈的栓塞性閉塞。

本報告提供急性缺血性腦中風的診斷及治療市場相關調查、各診斷、手術、地區的趨勢、2012∼2020年的市場成長預測,及加入此市場的主要企業簡介彙整。

第1章 序論

第2章 摘要整理

第3章 市場概要

  • 概要
  • 活動影響分析
  • 推動市場的要素
    • 患者數的增加
    • 技術創新
  • 阻礙市場的要素
    • 替代治療與成本高
  • 市場機會
    • 亞太地區的巨大數量的潛在患者數對治療藥開發廠商來說是收益成長的機會
  • 價值鏈分析
  • 波特五力分析
  • 市場魅力度分析
  • 競爭環境
    • 市場佔有率分析;:2013年

第4章 各診斷市場

  • 概要
  • CT
  • MRI
  • 超音波
  • 腦血管造影術
  • 核子醫學攝影
  • 其他

第5章 各手術

  • 概要
  • 頸動脈內薄膜剝離術
  • 血管新生
  • 血管內機械性血栓消除術

第6章 各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他各國

第7章 建議

第8章 企業簡介

  • Abbott Laboratories
  • Covidien plc
  • Johnson & Johnson
  • Penumbra, Inc.
  • Philips Healthcare
  • GE Healthcare
  • 株式會社日立製作所
  • Siemens Healthcare
  • Stryker Corporation
目錄

Acute ischemic stroke can be defined as interruption of blood supply to the brain due to the blockage of blood vessel due to atherosclerosis plaques or blood clots in the artery. Acute ischemic stroke can caused due to thrombotic or embolic occlusion of cerebral artery. This research report on acute ischemia diagnosis and treatment market explains various advancements occurring in this market and analyzes the global acute ischemic stroke diagnosis and treatment market by diagnosis types and surgery types as well as geographic regions. This report comprises of an elaborate executive summary, which includes a market snapshot that provides a market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram which is drawn that reflects the market size of various segments in descending order.

The global market for acute ischemic stroke diagnosis and treatment is segmented based on diagnosis such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), ultrasound, cerebral angiography, nuclear imaging and others. The market for these diagnosis types has been extensively analyzed based on consistency, effectiveness and sales revenue of the product developed by the manufacturers. The market size and forecast in terms of USD million for each diagnosis type has been provided for the period 2012 to 2020. The report on the acute ischemic stroke diagnosis and treatment market also provides % compounded annual growth rate (CAGR) for each of the aforementioned market segment for the forecast period 2014 to 2020, considering 2013 as the base year.

In addition, the global market for acute ischemic stroke diagnosis and treatment is segmented based on the surgery types. The segment is categorized into carotid endarterectomy, angioplasty and endovascular mechanical thrombectomy. The market for these surgeries of acute ischemic stroke treatment has been extensively analyzed based on number of surgeries performed and cost of surgery. The market size and forecast in terms of USD million for each segment has been provided for the period 2012 to 2020. The report on the acute ischemic stroke diagnosis and treatment market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2014 to 2020, considering 2013 as the base year.

Geographically, the acute ischemic stroke diagnosis and treatment market has been categorized into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The market size and forecast for each of these regions have been provided for the period 2012 to 2020 along with CAGR (%) for the forecast period 2014 to 2020. The research study also incorporates the competitive scenario of major players in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global acute ischemic stroke diagnosis and treatment market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter's five forces analysis, and key players' market share analysis in 2013 in the acute ischemic stroke diagnosis and treatment market.

This research report also explains about value chain (distribution) analysis from the supplier of the raw material to the end-users (hospital, patient). One event impact analysis chart is also includes in this report that describe event and their impact associated with this market from 2012 to 2020.

A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase market share. The report concludes with the profiles of major players in the acute ischemic stroke diagnosis and treatment market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major market players profiled in this report includes Covidien plc, Johnson and Johnson, Stryker Corporation, Abbott Laboratories, Hitachi Medical Corporation, GE healthcare, Penumbra, Inc. and Philips Healthcare.

The global acute ischemic stroke diagnosis and treatment market is segmented as follows:

Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Cerebral Angiography
  • Nuclear Imaging
  • Others

Acute Ischemic Stroke Diagnosis and Treatment Market, by Surgery Type

  • Carotid Endarterectomy
  • Angioplasty
  • Endovascular Mechanical Thrombectomy

Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
    • 1.3.1 Assumptions
  • 1.4 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Overview
  • 2.2 Market Snapshot: Global Acute Ischemic Stroke Diagnosis and Treatment Market (2013 & 2020)
  • 2.3 Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Types , 2013 (USD Million)
  • 2.4 Comparative Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography, 2013 and 2020 (Value %)

Chapter 3 Market Overview

  • 3.1 Overview
  • 3.2 Event Impact Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market
  • 3.3 Market Drivers
    • 3.3.1 Rising number of acute stroke patients aiding the growth of diagnosis and treatment market
    • 3.3.2 Technological innovations in diagnostic and surgical devices boosts market growth
  • 3.4 Restraints
    • 3.4.1 Alternative treatments and high cost are posing a threat for the growth of the market
  • 3.5 Opportunities
    • 3.5.1 Huge potential patient in Asia-Pacific creates opportunity for acute ischemic stroke product developers record high growth in revenue
  • 3.6 Value Chain Analysis
  • 3.7 Porter's Five Force Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market
    • 3.7.1 Bargaining power of suppliers
    • 3.7.2 Bargaining power of buyers
    • 3.7.3 Threat of new entrants
    • 3.7.4 Threat of substitutes
    • 3.7.5 Competitive rivalry
  • 3.8 Market Attractiveness Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography
  • 3.9 Competitive Landscape
    • 3.9.1 Market Share Analysis by Key Players, 2013 (Value %)

Chapter 4 Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type

  • 4.1 Overview
    • 4.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Diagnostic Types, 2012 - 2020 (USD Million)
  • 4.2 Computed Tomography
    • 4.2.1 Global Computed Tomography Market Revenue, 2012 - 2020 (USD Million)
  • 4.3 Magnetic Resonance Imaging
    • 4.3.1 Global Magnetic Resonance Imaging Market Revenue, 2012 - 2020 (USD Million)
  • 4.4 Ultrasound
    • 4.4.1 Global Ultrasound Market Revenue, 2012 - 2020 (USD Million)
  • 4.5 Cerebral angiography
    • 4.5.1 Global Cerebral Angiography Market Revenue, 2012 - 2020 (USD Million)
  • 4.6 Nuclear Imaging
    • 4.6.1 Global Nuclear Imaging Market Revenue, 2012 - 2020 (USD Million)
  • 4.7 Others
    • 4.7.1 Global Others Market Revenue, 2012 - 2020 (USD Million)

Chapter 5 Acute Ischemic Stroke Diagnosis and Treatment Market by, Surgery Type

  • 5.1 Overview
    • 5.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Surgery Type, 2012 - 2020 (USD Million)
  • 5.2 Carotid Endarterectomy
    • 5.2.1 Global Carotid Endarterectomy Market Revenue, 2012 - 2020 (USD Million)
  • 5.3 Angioplasty
    • 5.3.1 Global Angioplasty Market Revenue, 2012 - 2020 (USD Million)
  • 5.4 Endovascular Mechanical Thrombectomy
    • 5.4.1 Global Endovascular Mechanical Thrombectomy Market Revenue, 2012 - 2020 (USD Million)

Chapter 6 Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography

  • 6.1 Overview
    • 6.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • 6.2 North America
    • 6.2.1 North America Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 - 2020 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 - 2020 (USD Million)
  • 6.4 Asia-Pacific
    • 6.4.1 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 - 2020 (USD Million)
  • 6.5 Rest of the World
    • 6.5.1 RoW Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 - 2020 (USD Million)

Chapter 7 Recommendations

  • 7.1 Rigorous research and development initiatives for innovative products
  • 7.2 Investing in emerging economies

Chapter 8 Company Profiles

  • 8.1 Abbott Laboratories
    • 8.1.1 Company Overview
    • 8.1.2 Financial Overview
    • 8.1.3 Product Portfolio
    • 8.1.4 Business Strategies
    • 8.1.5 Recent Developments
  • 8.2 Covidien plc
    • 8.2.1 Company Overview
    • 8.2.2 Financial Overview
    • 8.2.3 Product Portfolio
    • 8.2.4 Business Strategies
    • 8.2.5 Recent Developments
  • 8.3 Johnson & Johnson (Cordis Corporation)
    • 8.3.1 Company Overview
    • 8.3.2 Financial Overview
    • 8.3.3 Product Portfolio
    • 8.3.4 Business Strategies
    • 8.3.5 Recent Developments
  • 8.4 Penumbra, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Overview
    • 8.4.3 Product Portfolio
    • 8.4.4 Business Strategies
    • 8.4.5 Recent Developments
  • 8.5 Philips Healthcare
    • 8.5.1 Company Overview
    • 8.5.2 Financial Overview
    • 8.5.3 Product Portfolio
    • 8.5.4 Business Strategies
    • 8.5.5 Recent Developments
  • 8.6 GE Healthcare
    • 8.6.1 Company Overview
    • 8.6.2 Financial Overview
    • 8.6.3 Product Portfolio
    • 8.6.4 Business Strategies
    • 8.6.5 Recent Developments
  • 8.7 Hitachi, Ltd.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Overview
    • 8.7.3 Product Portfolio
    • 8.7.4 Business Strategies
    • 8.7.5 Recent Developments
  • 8.8 Siemens Healthcare
    • 8.8.1 Company Overview
    • 8.8.2 Financial overview
    • 8.8.3 Product Portfolio
    • 8.8.4 Business Strategies
    • 8.8.5 Recent Developments
  • 8.9 Stryker Corporation (Concentric Medical, Inc.)
    • 8.9.1 Company Overview
    • 8.9.2 Financial Overview
    • 8.9.3 Product Portfolio
    • 8.9.4 Business Strategies
    • 8.9.5 Recent Developments

List of Figures

  • FIG. 1 Acute Ischemic Stroke Diagnosis and Treatment: Market Segmentation
  • FIG. 2 Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Types, 2013 (USD Million)
  • FIG. 3 Comparative Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography, 2013 & 2020 (Value %)
  • FIG. 5 Porter's Five Forces Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market
  • FIG. 6 Market Attractiveness Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography, 2013 Value (%)
  • FIG. 7 Market Share Analysis: Acute Ischemic Stroke Diagnosis and Treatment Market, 2013 (Value %)
  • FIG. 8 Global Computed Tomography Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 9 Global Magnetic Resonance Imaging Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 10 Global Ultrasound Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 11 Global Cerebral Angiography Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 12 Global Nuclear Imaging Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 13 Global Others Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 14 Global Carotid Endarterectomy Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 15 Global Angioplasty Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 16 Global Endovascular Mechanical Thrombectomy Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 17 North America Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 18 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 19 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 20 RoW Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 21 Abbott Laboratories: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 22 Covidien plc: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 23 Johnson & Johnson: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 24 Philips Healthcare: Annual Revenue,2011 - 2013 (USD Million)
  • FIG. 25 GE Healthcare: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 26 Hitachi, Ltd.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 27 Siemens Healthcare: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 28 Stryker Corporation: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 List of Abbreviations
  • TABLE 2 Market Snapshot: Global Acute Ischemic Stroke Diagnosis and Treatment Market (2013 & 2020)
  • TABLE 3 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Diagnostic Types, 2012 - 2020 (USD Million)
  • TABLE 4 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Surgery Type, 2012 - 2020 (USD Million)
  • TABLE 5 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Geography, 2012 - 2020 (USD Million)
Back to Top